Page 3 - தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் நி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் நி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் நி Today - Breaking & Trending Today

Researchers Unveil Detailed Genome of Invasive Malaria Mosquito


Researchers Unveil Detailed Genome of Invasive Malaria Mosquito
New ‘gold standard’ reference genome reveals thousands of new genes vital for targeting pathogen transmission and immunity
Adult female Anopheles stephensi mosquito.
Newswise Despite the broad notoriety of sharks, snakes, scorpions and other formidable creatures, mosquitoes remain the deadliest animal on the planet… by far. Mosquito-transmitted malaria remains the number one worldwide killer among vector-borne diseases, claiming more than 400,000 human lives in 2019.
In order to engineer advanced forms of defense against malaria transmission, including targeted CRISPR and gene drive-based strategies, scientists require intricate knowledge of the genomes of vector mosquitoes.
Mahul Chakraborty a project scientist at the University of California, Irvine, working with colleagues at the Tata Institute for Genetics and Society (TIGS) at UC San Diego and India, and the Institute of Bioinformatics ....

United States , San Diego , Luna Thanh Ngo , Anthony James , Suvratha Jayaprasad , Subhashini Srinivasan , Suresh Subramani , Arunachalam Ramaiah , Kiran Paul , Saurabh Whadgar , Bhagyashree Kaduskar , Mahul Chakraborty , Paige Halas , Adriana Adolfi , University Of California , Tata Institute For Genetics , Institute Of Bioinformatics , National Institutes Of Health , Synbal Inc , Agragene Inc , Division Of Biological Sciences , Tata Institute , Applied Biotechnology , South Asia , Ethan Bier , Director Suresh Subramani ,

Ride Health gives patients a lift to COVID-19 treatment, vaccine trials


Through the Ride Health platform, a study coordinator can request rides on behalf of participants. (Ride Health)
Access to private transportation, or lack thereof, has long been a barrier to participation in clinical trials. And COVID-19 isn’t making things easier, with public health guidelines discouraging the use of public transport and ride-hailing services setting up policies against passengers with COVID-19 symptoms.
So, how are institutions running COVID-19 trials getting patients in for site visits? New York-based Ride Health is on the job.
The company is partnering with ACTIV-2, a study backed by the National Institutes of Health (NIH) testing treatments for COVID-19, and the NIH-founded COVID-19 Prevention Trials Network (CoVPN), the “harmonizer” network for the five vaccine trials backed by Operation Warp Speed. It will provide transportation to and from study sites for participants through its network of COVID-19-equipped providers. That means ....

Puerto Rico , South Dakota , United States , Judith Currier , Eli Lilly , Imran Cronk , Amin Farhoomand , Centers For Disease , National Institutes Of Health , Nstride Health , Clinical Trials Group , Amin Farhoomand Ride Health , Imran Cronk Ride Health , Prevention Trials Network Co , New York Based Ride Health , National Institutes , Trials Network , Operation Warp , Disease Control , Trials Group , Corona Virus , National Institutes Of Health Nih , Covid 19 , Clinical Research , ப்வெர்டோ ரிக்கோ , தெற்கு டகோட்டா ,